HK1021685A1 - Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease - Google Patents

Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease

Info

Publication number
HK1021685A1
HK1021685A1 HK98114128A HK98114128A HK1021685A1 HK 1021685 A1 HK1021685 A1 HK 1021685A1 HK 98114128 A HK98114128 A HK 98114128A HK 98114128 A HK98114128 A HK 98114128A HK 1021685 A1 HK1021685 A1 HK 1021685A1
Authority
HK
Hong Kong
Prior art keywords
patients
treatment
liver disease
containing compositions
decompensated liver
Prior art date
Application number
HK98114128A
Other languages
English (en)
Inventor
Paul B Chretien
Milton Mutchnick
Original Assignee
Sciclone Pharmaceuticals Inc
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1993/010619 external-priority patent/WO1995012405A1/en
Application filed by Sciclone Pharmaceuticals Inc, Univ Wayne State filed Critical Sciclone Pharmaceuticals Inc
Publication of HK1021685A1 publication Critical patent/HK1021685A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK98114128A 1993-11-05 1998-12-19 Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease HK1021685A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/010619 WO1995012405A1 (en) 1993-11-05 1993-11-05 Method and composition for treatment of patients having decompensated liver disease

Publications (1)

Publication Number Publication Date
HK1021685A1 true HK1021685A1 (en) 2000-06-23

Family

ID=22237139

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98114128A HK1021685A1 (en) 1993-11-05 1998-12-19 Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease

Country Status (11)

Country Link
EP (1) EP0731710B1 (no)
KR (1) KR100298859B1 (no)
CA (1) CA2175337C (no)
DE (1) DE69332982T2 (no)
DK (1) DK0731710T3 (no)
ES (1) ES2194860T3 (no)
HK (1) HK1021685A1 (no)
MX (1) MXPA94003453A (no)
MY (1) MY111342A (no)
NO (1) NO961775D0 (no)
PT (1) PT731710E (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (no) * 1991-09-13 1994-05-21 Paul B Chretien
EP0728010A4 (en) * 1992-02-06 1997-10-01 Sciclone Pharmaceuticals METHOD FOR TREATING HEPATITIS B CARRIERS WITH A MINOR DISEASE
AU4671193A (en) * 1992-07-13 1994-01-31 Kenneth E. Sherman Composition and method of treating hepatitis b

Also Published As

Publication number Publication date
NO961775L (no) 1996-05-02
DK0731710T3 (da) 2003-06-16
PT731710E (pt) 2003-09-30
EP0731710B1 (en) 2003-05-14
KR100298859B1 (ko) 2001-10-22
DE69332982T2 (de) 2004-09-09
DE69332982D1 (de) 2003-06-18
ES2194860T3 (es) 2003-12-01
CA2175337A1 (en) 1995-05-11
CA2175337C (en) 2000-06-20
NO961775D0 (no) 1996-05-02
EP0731710A1 (en) 1996-09-18
KR960706352A (ko) 1996-12-09
MY111342A (en) 1999-11-30
MXPA94003453A (es) 2004-08-16
EP0731710A4 (en) 1999-12-22

Similar Documents

Publication Publication Date Title
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
EP0735870A4 (en) USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE
EP0511868A3 (en) Medical or dental hardening compositions
HU9300536D0 (en) Compounds of medical effect
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL105285A0 (en) Compositions for the treatment of diabetes
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
ITRM910146V0 (it) Strumento chirurgico per l'introduzione di protesi peniene
HK1021685A1 (en) Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IL104756A0 (en) Composition for the treatment of glaucoma
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091105